Evidence map›Paper›PMID 35177103›Full record

ArticleJournal of orthopaedic surgery and research2022

Attenuation of osteoarthritis progression through intra-articular injection of a combination of synovial membrane-derived MSCs (SMMSCs), platelet-rich plasma (PRP) and conditioned medium (secretome).

Sara Sadat Nabavizadeh, Tahereh Talaei-Khozani, Moein Zarei, Shahrokh Zare, Omid Koohi Hosseinabadi, Nader Tanideh, Sajad Daneshi

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic surgery and research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Orthobiologics in knee osteoarthritis, dream or reality?Archives of orthopaedic and trauma surgery · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Sara Sadat Nabavizadeh *Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Tahereh Talaei-Khozani *Department of Anatomical Sciences, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Moein ZareiDepartment of Polymer and Biomaterials Science, Western Pomeranian University of Technology, Szczecin, Al. Piastow 45, 71-311, Szczecin, Poland.
Shahrokh ZareStem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Omid Koohi HosseinabadiCentral Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran.
Nader TanidehStem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. tanidehn@gmail.com.
Sajad DaneshiStem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. sa.daneshi@yahoo.com.ORCID http://orcid.org/0000-0002-3804-1444
Shiraz University of Medical Sciences · IRWest Pomeranian University of Technology in Szczecin · PL

Funding

vice-chancellor for research, shiraz university of medical sciences 10171
6 · The paper itself

Abstract

purposeOsteoarthritis (OA) as a progressive destructive disease of articular cartilage is the most common joint disease characterized by reduction of joint cartilage thickness, demolition of cartilage surface and new bone formation. To overcome these problems, the purpose of the current research was to evaluate and compare the in vivo effects of synovial membrane-derived mesenchymal stem cell (SMMSCs), platelet-rich plasma (PRP) and conditioned medium (secretome) on collagenase II-induced rat knee osteoarthritis (KOA) remedy.

methodsFor the first step, SMMSCs were isolated and characterized. Also, secretome was collected from SMMSCs culture. Furthermore, PRP was collect from the rat heart venous blood. Second, two injection of collagenase II with an interval of 3 days was performed in the knee intra-articular space to induce osteoarthritis. Two weeks later, animals were randomly divided into 6 groups. Control group without treatment, positive group: taken an intra-articular sodium hyaluronate injection (0.1 ml), treatment groups taken an intra-articular injection of; treatment 1: SMMSCs (5 × 10

resultsOur findings represented that a combination of the SMMSCs/secretome/PRP had a considerable effect on glycosaminoglycans (GAGs) and collagen II contents, articular cartilage preservation, compared with other groups. In addition, combination of the SMMSCs with PRP and secretome showed the lowest expression of mmp3, while SOX9 had the highest expression in comparison with other groups. Also, SMMSCs-injected groups demonstrated better results compared with positive and control groups.

conclusionsInjecting a combination of the SMMSCs/secretome/PRP resulted in better efficacy in terms of joint space width, articular cartilage surface continuity and integrity, sub-chondral bone and ECM constituents such as collagen II. Indeed, transplantation of this combination could be considered as a preliminary therapy for clinical trial study in the future.

Indexed as

SecretomeAnimalsCulture Media, ConditionedInjections, Intra-ArticularOsteoarthritis, KneePlatelet-Rich PlasmaRatsSynovial MembraneTreatment OutcomeCulture Media, ConditionedMesenchymal stem cellsOsteoarthritisPRPRatSecretome

Identifiers

PMID35177103
PMCPMC8851803
OpenAlexW4212959542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.